← Back to Search

Tailored Best Practices for Intellectual Disability

N/A
Waitlist Available
Led By Stephen J Bartels, MD, MS
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the outcome will be measured 3 months after intervention implementation.
Awards & highlights

Study Summary

This trial will help create a package of interventions to reduce the spread of COVID-19 and other infectious diseases among staff and people with mental illness and developmental disabilities who live in congregate settings.

Eligible Conditions
  • Intellectual Disability
  • Axis I Disorder
  • Coronavirus
  • Developmental Disability
  • Mental Health Disorders
  • Coronavirus Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the outcome will be measured 3 months after intervention implementation.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the outcome will be measured 3 months after intervention implementation. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Best Practices Fidelity at 12 Months
Best Practices Fidelity at 15 Months
Best Practices Fidelity at 3 Months
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Tailored Best Practices (TBP)Experimental Treatment1 Intervention
The ~200 group homes randomized into this arm will receive the Tailored Best Practices (TBP) intervention package as part of routine training activities. TBP consists of COVID-19 mitigation measures specifically adapted for staff and residents with SMI and ID/DD in congregate living settings. Sites in this arm will receive coaching specific to the setting, staff, and residents.
Group II: Generic Best Practices (GBP)Active Control1 Intervention
The ~200 group homes randomized into this arm will receive the Generic Best Practices (GBP) intervention package as part of routine training activities. GBP consists of state and federal standard guidelines for COVID-19 mitigation for all congregate living settings.

Find a Location

Who is running the clinical trial?

Dartmouth CollegeOTHER
82 Previous Clinical Trials
1,410,900 Total Patients Enrolled
Vinfen CorporationUNKNOWN
1 Previous Clinical Trials
240 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
2,941 Previous Clinical Trials
13,195,319 Total Patients Enrolled
1 Trials studying Intellectual Disability
280 Patients Enrolled for Intellectual Disability

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings
Stephen Bartels 2021. "Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04726371.
All > Mental Illness
~1235 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top